Gu X - Search Results

1

Correction: ZNF774 is a potent suppressor of hepatocarcinogenesis through dampening the NOTCH2 signaling.

Guan C, He L, Chang Z, Gu X, Liang J, Liu R. Guan C, et al. Among authors: gu x. Oncogene. 2020 Mar;39(13):2844. doi: 10.1038/s41388-020-1180-0. Oncogene. 2020. PMID: 32015484

2

ZNF774 is a potent suppressor of hepatocarcinogenesis through dampening the NOTCH2 signaling.

Guan C, He L, Chang Z, Gu X, Liang J, Liu R. Guan C, et al. Among authors: gu x. Oncogene. 2020 Feb;39(8):1665-1680. doi: 10.1038/s41388-019-1075-0. Epub 2019 Oct 28. Oncogene. 2020. PMID: 31659254

3

MTA2 promotes HCC progression through repressing FRMD6, a key upstream component of hippo signaling pathway.

Guan C, Chang Z, Gu X, Liu R. Guan C, et al. Among authors: gu x. Biochem Biophys Res Commun. 2019 Jul 12;515(1):112-118. doi: 10.1016/j.bbrc.2019.05.025. Epub 2019 May 22. Biochem Biophys Res Commun. 2019. PMID: 31128910

4

Application of 18F-FDG PET/CT combined with carbohydrate antigen 19-9 for differentiating pancreatic carcinoma from chronic mass-forming pancreatitis in Chinese elderly.

Gu X, Liu R. Gu X, et al. Clin Interv Aging. 2016 Sep 29;11:1365-1370. doi: 10.2147/CIA.S115254. eCollection 2016. Clin Interv Aging. 2016. PMID: 27729779 Free PMC article.

5

GATA1 Promotes Gemcitabine Resistance in Pancreatic Cancer through Antiapoptotic Pathway.

Chang Z, Zhang Y, Liu J, Guan C, Gu X, Yang Z, Ye Q, Ding L, Liu R. Chang Z, et al. Among authors: gu x. J Oncol. 2019 Apr 10;2019:9474273. doi: 10.1155/2019/9474273. eCollection 2019. J Oncol. 2019. PMID: 31093285 Free PMC article.

6

[Application of ¹⁸F-fluorodeoxyglucose positron emission tomography/computed tomography in preoperative assessment of hilar cholangiocarcinoma].

Gu XJ, Wang BF, Liu R. Gu XJ, et al. Zhonghua Yi Xue Za Zhi. 2012 May 29;92(20):1409-12. Zhonghua Yi Xue Za Zhi. 2012. PMID: 22883200 Chinese.

7

Preoperative maximum standardized uptake value and carbohydrate antigen 19-9 were independent predictors of pathological stages and overall survival in Chinese patients with pancreatic duct adenocarcinoma.

Gu X, Zhou R, Li C, Liu R, Zhao Z, Gao Y, Xu Y. Gu X, et al. BMC Cancer. 2019 May 15;19(1):456. doi: 10.1186/s12885-019-5691-4. BMC Cancer. 2019. PMID: 31092213 Free PMC article.

8

Exosomal piRNA profiling revealed unique circulating piRNA signatures of cholangiocarcinoma and gallbladder carcinoma.

Gu X, Wang C, Deng H, Qing C, Liu R, Liu S, Xue X. Gu X, et al. Acta Biochim Biophys Sin (Shanghai). 2020 May 26;52(5):475-484. doi: 10.1093/abbs/gmaa028. Acta Biochim Biophys Sin (Shanghai). 2020. PMID: 32369104 Free article. Clinical Trial.

9

Retroperitoneoscopic pancreatectomy: a new surgical option for pancreatic disease.

Zhao G, Xue R, Ma X, Hu M, Gu X, Wang B, Zhang X, Liu R. Zhao G, et al. Among authors: gu x. Surg Endosc. 2012 Jun;26(6):1609-16. doi: 10.1007/s00464-011-2078-2. Epub 2011 Dec 17. Surg Endosc. 2012. PMID: 22179465

10

Identification of exosomal miRNAs as diagnostic biomarkers for cholangiocarcinoma and gallbladder carcinoma.

Xue XY, Liu YX, Wang C, Gu XJ, Xue ZQ, Zang XL, Ma XD, Deng H, Liu R, Pan L, Liu SH. Xue XY, et al. Signal Transduct Target Ther. 2020 Jun 12;5(1):77. doi: 10.1038/s41392-020-0162-6. Signal Transduct Target Ther. 2020. PMID: 32527999 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

10,852 results

Search Page

Filters